KaraRoodMD

Obstetrics & Gynecology • Columbus, OH

Maternal & Fetal Medicine/High Risk

Physician

Join to view full profile

Dr. Rood is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rood's full profile

Already have an account?

Office
2050 Kenny Rd
6th Fl Tower
Columbus, OH 43221
Phone+1 614-293-2222

Fax+1 614-293-2200

Summary

Dr. Kara Rood is an obstetrician/gynecologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Hospital, James Cancer Hospital and Solove Research Institute, and Ohio State University Wexner Medical Center. She received her medical degree from Saba University School of Medicine and has been in practice 8 years. She specializes in maternal & fetal medicine/high risk and is experienced in maternal and fetal medicine, high-risk pregnancies, and fetal surgery.

Education & Training

Ohio State University/Mt Carmel HospitalFellowship, Maternal-Fetal Medicine, 2013 - 2016
Bridgeport Hospital/Yale UniversityResidency, Obstetrics and Gynecology, 2009 - 2013
Saba University School of MedicineClass of 2009

Certifications & Licensure

OH State Medical License 2013 - 2026
PA State Medical License 2012 - 2012
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia Start of enrollment: 2017 Oct 30
Completed
Phase 4
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia Start of enrollment: 2019 Aug 19
Completed
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor Start of enrollment: 2020 Jun 09
Completed
Phase 4
Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI) Start of enrollment: 2021 Dec 01
Completed
Roles: Contact, Principal Investigator
TrueRelief Efficacy for Post-cesarean Pain (ELECTRON) Start of enrollment: 2022 Apr 18
Completed
Not Applicable
Roles: Contact, Principal Investigator
The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia Start of enrollment: 2019 Jan 15
Terminated
Phase 4
Roles: Contact, Principal Investigator
EASE: The Materna Prep Pivotal Study Start of enrollment: 2019 Dec 11
Recruiting
Not Applicable
Roles: Contact
Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING) Start of enrollment: 2022 Jun 08
Completed
Roles: Principal Investigator, Contact
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy Start of enrollment: 2022 Apr 04
RECRUITING
PHASE4
Roles: Contact
EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE) Start of enrollment: 2024 Jul 02
RECRUITING
Roles: Contact
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Start of enrollment: 2024 Oct 18
RECRUITING
PHASE4
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Real-world use of a vacuum-induced hemorrhage-control device in births <34 weeks gestational age.
Kara M Rood, Angela Bianco, Joseph R Biggio, Marcela C Smid, Hyagriv N Simhan
The Journal of Maternal-Fetal & Neonatal Medicine. 2025-12-01
Hepatitis C Virus Infection in Pregnant Individuals with Opioid Use Disorder and Its Association with Preterm Birth.
Aneesha Cheedalla, Marissa Berry, Mahmoud Abdelwahab, Jamie Cowen, Alexandra Stiles
American Journal of Perinatology. 2025-04-01
Using ICD Codes Alone May Misclassify Overdoses Among Perinatal People.
Amy Board, Alana Vivolo-Kantor, Shin Y Kim, Emmy L Tran, Shawn A Thomas
American Journal of Preventive Medicine. 2025-03-01

Journal Articles

52 Vaginal Isosorbide Mononitrate for Labor Induction in Pregnancies Complicated by Hypertensive Diseases of Pregnancy
Stephen Thung, Kara Rood, American Journal of Obstetrics and Gynecology
1108 Balloon Tamponade Versus a Novel Vacuum-Induced Hemorrhage Control Device for Treatment of Postpartum Uterine Bleeding
Hyagriv Simhan, Angela R Seasely, Akila Subramaniam, Kara M Rood, American Journal of Obstetrics and Gynecology
775 Racial and Ethnic Disparities in Rates and Success of Trial of Labor After Cesarean
Matthew M Finneran, Kara M Rood, Rupsa C Boelig, American Journal of Obstetrics and Gynecology
High Frequency of Posttraumatic Stress Symptoms Among U.S. Obstetric and Gynecologic Providers During the COVID-19 Pandemic
Kartik K Venkatesh, Kara M Rood, American Journal of Obstetrics and Gynecology
Join now to see all

Press Mentions

Mirvie RNA Platform Predicts Severe Fetal Growth Restriction Months Before BirthJanuary 30th, 2025
Materna Medical Announces Publication of EASE Pilot StudyAugust 6th, 2024
Alydia Health Announces FDA Clearance and Publication of Pivotal Study of Innovative Treatment for Leading Cause of Maternal Injury and DeathSeptember 9th, 2020
Join now to see all

KaraRoodMD

Dr. Rood is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.